Skip to content
Palanor is in early release, with our founding customers.Become a founding customer →
PalanorPalanor
← The Lattice

equities · NYSE

Eli Lilly & Co. (LLY)

eq-lly

Latest

1.3KUSD

30d change

+13.2%

Description

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Read deeper

The full chart, methodology, and Numen's reading open with a free account.

Cookies

We only use essential cookies to keep you signed in and remember your theme. No analytics, no tracking, no ads. See the Privacy Policy for the full read.